Articles By Marcus Johnson
-
Baxter To Split Into Two Companies
3/28/2014
Baxter International has released a statement detailing its intention to break the company into two smaller companies.
-
US And Japanese Regulators Differ On Kidney Disease Drug
3/28/2014
US and Japanese regulators have reached different conclusions on a rare kidney disease drug produced by Otsuka Pharmaceutical Co.
-
University of Florida Researchers Say Gold-Based Drug Shows Promise
3/26/2014
Researchers at the University of Florida have been working on a treatment for osteosarcoma, an aggressive form of bone cancer that affects both humans and dogs. Researchers determined that the drug aurothiomalate, or gold salts, helped to stop cancer cells from forming.
-
Animal Testing Reduced By Creation Of New Drug Research Technology
3/25/2014
New technology is making it easier to develop effective pharamceutical drugs without the use of animal testing.
-
WHO Wants Help Fighting Drug-Resistant TB
3/25/2014
The WHO is asking the international medical and pharamcetuical industries to help combat tuberculosis (TB).
-
Rate Of Drug Spending Slowing In Canada With Availability Of Generics
3/10/2014
Canadians are spending more money than ever on prescription drugs, but the rate of spending growth has slowed down with the availability of generic drugs.
-
Stem Cells Driving Alzheimer's Research
3/7/2014
Stem cell researchers from Harvard have been able to turn patients’ skin cells into neurons that can be affected by early-onset Alzheimer’s.
-
HIV Prevention Treatment Has Major Potential
3/6/2014
New research at the Gladstone Institutes is focused on improving HIV prevention. The Gladstone Institutes are associated with the University of California, San Francisco.
-
Study Claims Patent Trolls Could Affect Drug Companies
3/6/2014
Patent trolls are typically associated with the technology industry and computer software. But a new study released by the University of California Hasting College of the Law professor Robin Feldman and Harvard Law School fellow Nicholson Price claims that patent trolls could soon find their way to the drug industry.
-
Researchers Studying Palau Coral Reefs For Cancer Drugs
3/4/2014
David Newman, leader of the Natural Products branch at the National Cancer Institute in Maryland, is interested in finding cancer drugs in unusual locations.